| __timestamp | Arrowhead Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 94231000 |
| Thursday, January 1, 2015 | 57410147 | 146394000 |
| Friday, January 1, 2016 | 41454452 | 188272000 |
| Sunday, January 1, 2017 | 31690298 | 166707000 |
| Monday, January 1, 2018 | 52968505 | 401843000 |
| Tuesday, January 1, 2019 | 81048686 | 560909000 |
| Wednesday, January 1, 2020 | 128874979 | 722343000 |
| Friday, January 1, 2021 | 206342000 | 771182000 |
| Saturday, January 1, 2022 | 297307000 | 877090000 |
| Sunday, January 1, 2023 | 353188000 | 877387000 |
| Monday, January 1, 2024 | 505870000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Sarepta Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to push the boundaries of medical science. From 2014 to 2023, Sarepta consistently outpaced Arrowhead, with R&D expenses peaking at nearly 880% higher than their 2014 levels by 2023. This commitment underscores Sarepta's aggressive strategy to lead in gene therapy and RNA-targeted therapeutics. Meanwhile, Arrowhead has shown a remarkable growth trajectory, with R&D spending increasing by over 2,000% during the same period, reflecting its focus on RNA interference technologies. As we look to the future, the missing data for 2024 leaves us eagerly anticipating which company will continue to lead in this vital area of innovation.
R&D Spending Showdown: AstraZeneca PLC vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Novartis AG and Arrowhead Pharmaceuticals, Inc.
GSK plc vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Intra-Cellular Therapies, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Vericel Corporation vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs Galapagos NV